Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deuterium Metabolic MRI and [18F]-Flourodesoxyglucose Positron Emission Tomography for Assessment of Treatment Response Following Radioembolization; Pilot Study

NCT06232889 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06232889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deuterium Metabolic MRI and [18F]-Flourodesoxyglucose Positron Emission Tomography for Assessment of Treatment Response Following Radioembolization; Pilot Study
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2024
Completion date
January 1, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fluorodeoxyglucose f18, phosphoric diester hydrolases, phosphoric monoester hydrolases